Search from website
Search from website
Last chance to meet in our 12th conference in 2022 the key Icosageneers Mart Ustav Jr., Meelis Kadaja, and Lauri Peil, to discuss collaboration and combined expertise on multi-span transmembrane antibodies, their discovery, transient mgs to clinical kgs GMP production, based on our unique #CRDMO concept.
Icosagen proudly sponsors Antibody Engineering & Therapeutics conference, and with it the latest science and research on antibody engineering, design and selection, as well as critical topics including immuno-oncology, cellular engagers, miniproteins, the Fc region, cancer therapy, novel bi-specifics/multi-specifics and much more.
Icosagen Cell Factory (CRDMO) seamlessly discovers, develops, and manufactures your pre-clinical and clinical protein candidates.
Follow Icosagen Therapeutics page on LinkedIn for the latest news developments and.